Overdose Deaths Drop Among Needle Program Users: A Study from Karolinska Institutet
A groundbreaking study from Karolinska Institutet reveals a significant decline in overdose deaths among individuals who inject drugs enrolled in the Stockholm needle and syringe program over a decade. The research, published in the Harm Reduction Journal, sheds light on the effectiveness of harm reduction interventions, including the take-home naloxone program, in reducing opioid overdose fatalities.
The study followed 4,192 individuals who attended the Stockholm needle and syringe program between 2013 and 2023, linking program data with the Swedish National Cause of Death Register. The findings are striking: all-cause mortality decreased over time, with the most notable change observed in opioid overdose deaths.
Opioid Overdose Mortality Declines Markedly
Opioid overdose was the leading cause of death, accounting for 53% of all fatalities. However, the mortality rate from opioid overdoses decreased significantly from 29.40 to 5.88 deaths per 1,000 person-years during the study period. This decline coincided with the introduction of take-home naloxone distribution in January 2018 and reduced reported opioid use among program participants.
Elin Holmén, a researcher at the Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, emphasizes, "We observe a clear decline in opioid overdose deaths over time. This strengthens the evidence that broader access to harm reduction interventions can make a difference."
Factors Associated with Risk
The study identified several factors associated with increased risk, including less frequent injecting and recent detoxification. In contrast, participation in opioid agonist therapy was linked to a lower risk of both all-cause mortality and opioid overdose death.
Holmén adds, "The results underline the importance of continuing to scale up opioid agonist therapy and ensuring that naloxone is readily available in high-risk settings, as these interventions can save lives."
Changing Causes of Death Over Time
While opioid overdose deaths decreased, mortality from disease-related causes, or natural causes, increased during the same period. This shift may indicate a growing need for broader health interventions for an aging and medically vulnerable population, beyond measures directly targeting overdose risk.
The researchers also suggest that supervised consumption sites, where drugs can be used under medical supervision, could be a complementary intervention to further prevent deaths.
Study Details and Funding
The study, titled 'All-cause mortality and overdose deaths among 4,192 people who inject drugs in Stockholm: a 10-year register-based cohort study,' was published in the Harm Reduction Journal on February 13, 2026. The authors report no competing interests, and the study was funded by ALF and the Swedish Research Council for Health, Working Life, and Welfare (Forte).
But here's where it gets controversial... The study's findings raise important questions about the role of supervised consumption sites in preventing deaths. While the researchers suggest they could be a complementary intervention, others argue that such sites may inadvertently encourage drug use and increase the risk of overdose. What do you think? Share your thoughts in the comments below!
